Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-24-000034 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
256.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.87% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
45.32% · OPTIONAL · VALID
Share-count growth 29th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.97% · CORE · VALID
Revenue growth 0th Own-history percentile · N=17
Evidence method Yoy · gp.fundamentals.revenue
-22.68% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
61.81% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
58.66% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
23.32% · CORE · VALID
R&D intensity 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.58% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.78% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 52.02%
Current 256.54%
Delta 204.51% Capex Intensity Decreased
Previous 10.25%
Current 8.87%
Delta -1.38% Cash Generation Increased
Previous 39.15%
Current 45.32%
Delta 6.17% Dilution Increased
Previous -2.56%
Current -1.97%
Delta 0.59% Growth Decreased
Previous 2.43%
Current -22.68%
Delta -25.10% Inventory Pressure Increased
Previous 13.35%
Current 61.81%
Delta 48.47% Margin Decreased
Previous 64.01%
Current 58.66%
Delta -5.35% Profitability Decreased
Previous 31.07%
Current 23.32%
Delta -7.75% R And D Intensity Increased
Previous 13.49%
Current 15.58%
Delta 2.09% Sbc Intensity Increased
Previous 2.44%
Current 2.78%
Delta 0.34% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.